Final Program
4njPuP
4njPuP
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
MONDAY • MAY 16 189<br />
P87<br />
P88<br />
P89<br />
P90<br />
P91<br />
P92<br />
P93<br />
P94<br />
Facilitator:<br />
P95<br />
P96<br />
P97<br />
P98<br />
P99<br />
P100<br />
Cytokine Levels as Predictors of Pulmonary Arterial<br />
Hypertension in Human Immunodeficiency Virus Seropositive<br />
Subjects/M. Henriques-Forsythe, T. Tewolde, M.B. Huang, H.W.<br />
Farber, A. Quarshie, V.C. Bond, Atlanta, GA, p.A3954<br />
Higher Prevalence of Pulmonary Hypertension Among an<br />
African American HIV-Infected Cohort/M. Henriques-Forsythe, T.<br />
Tewolde, R. Lapu-Bula, H.W. Farber, A. Onwuanyi, Atlanta, GA,<br />
p.A3955<br />
Efficacy and Safety of Inhaled Sodium Nitrite in Pulmonary<br />
Hypertension Associated with Heart Failure with Preserved<br />
Ejection Fraction/M.A. Simon, R.R. Vanderpool, T.N. Bachman, P.<br />
White, E.L. Parsley, M.T. Gladwin, Pittsburgh, PA, p.A3956<br />
Neutrophil- to-Lymphocyte Ratio Predicts Survival in<br />
Pulmonary Arterial Hypertension Patients/V. Foris, G. Kovacs,<br />
P. Douschan, A. Avian, A. Olschewski, H. Olschewski, Graz,<br />
Austria, p.A3957<br />
Characteristics of Precapillary Pulmonary Hypertension in<br />
Elderly and Very Elderly Patients/M. Ginoux, S. Turquier, J.C.<br />
Glerant, J. Traclet, C. Khouatra, F. Philit, A. Senechal, J.-F.<br />
Mornex, V. Cottin, Bron, France, p.A3958<br />
Is Right Heart Catheterization Justified in Very Elderly<br />
Patients?/M. Ginoux, V. Cottin, J.C. Glerant, J. Traclet, C.<br />
Khouatra, F. Philit, A. Senechal, J.-F. Mornex, S. Turquier, Bron,<br />
France, p.A3959<br />
Circulating RNA as Potential Biomarkers in Pulmonary<br />
Hypertension/I. Singh, K. Max, D. Berger, K. Bogardus, T. Tuschl,<br />
E. Horn, K. Akat, New York, NY, p.A3960<br />
Using Near-Infrared Spectroscopy to Characterize the Effects<br />
of Inhaled Nitric Oxide on Skeletal Muscle Oxygen Saturation<br />
in Adults with Pulmonary Arterial Hypertension/B.D. Shaller, C.<br />
Kholdani, H. Hedlin, A.J. Sweatt, A. Hsi, E.F. Spiekerkoetter, R.T.<br />
Zamanian, Stanford, CA, p.A3961<br />
N. Al-Naamani, MD, Boston, MA<br />
The Spatial Distribution of Pulmonary Blood Flow in Adults<br />
Who Have Undergone Fontan Procedure/S.R. Hopkins, B.F.<br />
Printz, R.C. Sa, H.G. El-Said, C.K. Davis, R.J. Theilmann, La Jolla,<br />
CA, p.A3962<br />
Pulmonary Arterial Hypertension: Effect of Online CME on<br />
Improving Treatment Decisions/J. Spyropoulos, C.C. Kearns,<br />
R.J. White, New York, NY, p.A3963<br />
Pulmonary Arterial Hypertension (PAH) Associated with<br />
Interferon Therapy: A Population Based Study/R. Papani, A.<br />
Duarte, Y.L. Lin, G. Sharma, Galveston, TX, p.A3964<br />
Portopulmonary Hypertension Following Splenectomy: A Mayo<br />
Clinic Experience/J.M. Segraves, R. Cartin-Ceba, M.J. Krowka,<br />
Rochester, MN, p.A3965<br />
Interstitial Lung Disease Associated Pulmonary Hypertension<br />
in China/L. Wang, Q.-H. Zhao, R. Jiang, S.-G. Gong, J. He, P.<br />
Yuan, J.-M. Liu, Shanghai, China, p.A3966<br />
Pulmonary Function Test Parameters in Patients with<br />
Scleroderma-Associated Pulmonary Arterial Hypertension and<br />
Correlation with Mean Pulmonary Artery Pressure and<br />
Pulmonary Vascular Resistance/V. Yap, A. Selvachandran, M.<br />
Zantah, R. Foley, D. Datta, Farmington, CT, p.A3967<br />
P101<br />
P102<br />
P103<br />
P104<br />
P105<br />
P106<br />
P107<br />
P108<br />
Facilitator:<br />
P109<br />
P110<br />
P111<br />
P112<br />
P113<br />
Does Riociguat Provide Clinical Improvement in Pulmonary<br />
Hypertension? - A Meta Analysis/M. Anantha Narayanan, A.<br />
Kanmanthareddy, H. Devineni, J. Baskaran, L.E. Morrow, T.O.<br />
Wichman, Omaha, NE, p.A3968<br />
Characteristics and Diagnoses of Elderly Patients Referred to<br />
a Pulmonary Vascular Clinic for Evaluation of Possible<br />
Pulmonary Arterial Hypertension/H. Edriss, K. Selvan, T.<br />
Denega, T. Rodrigues, K. Nugent, Lubbock, TX, p.A3969<br />
Safety and Tolerability of Outpatient Transition of Parenteral<br />
and Inhaled Treprostinil to Oral Treprostinil in Patients with<br />
Pulmonary Arterial Hypertension/A.A. Khan, K. Ackerbauer, R.<br />
Tandon, Chicago, IL, p.A3970<br />
A Comparison of Safety and Pharmacokinetics of<br />
Esuberaprost (BPS-314d-MR) in Subjects with Normal, Mild<br />
and Moderate Hepatic Impairment/K.R.B.V. Kessler, T. Marbury,<br />
K. Lasseter, J. Berg, G. Patel, X. Chen, S. Peychal, J. Shin, P.<br />
Sista, Silver Spring, MD, p.A3971<br />
Connective Tissue Disease Associated Pulmonary Arterial<br />
Hypertension (CTD-PAH) - Prognosis, Predictors and<br />
Outcomes (PROPOS) Study/R. Ronaghi, B. Doremus, A.I. Khan,<br />
V. Balasubramanian, Fresno, CA, p.A3972<br />
Diabetes and Group III Pulmonary Hypertension: A Matched<br />
Case-Control Study/V.K. Singh, A.M. Morris, P. George,<br />
Monroeville, PA, p.A3973<br />
Pulmonary Capillary Wedge Pressure (PCWP) and Its Role in<br />
Determining Outcomes in Pulmonary Arterial Hypertension<br />
(PAH)/S. Venepally, R. Ronaghi, A.I. Khan, V. Balasubramanian,<br />
Fresno, CA, p.A3974<br />
Evaluating the Role of a Pulmonary Hypertension Specialist<br />
Nurse in Early Referral/L.E. Loewenthal, E.J. Shaw, B.P.<br />
Brendan, London, United Kingdom, p.A3975<br />
H.J. Ford, MD, Chapel Hill, NC<br />
Clinical Significance of Detecting Pulmonary Arterio-Venous<br />
Malformations with Chest Radiographs/K. Yamamoto, T.<br />
Sugiura, Y. Kasahara, S. Sakao, N. Tanabe, K. Tatsumi, Chiba,<br />
Japan, p.A3976<br />
TRANSIT-1: Evaluation of Transition from Inhaled Treprostinil<br />
to Oral Selexipag/A. Frost, R.L. Benza, H. Farber, N.H. Kim, B.K.<br />
Hartline, T. Pfister, Y. Shiraga, V. McLaughlin, Houston, TX,<br />
p.A3977<br />
Low Rate of Adverse Events Associated with Inpatient<br />
Parenteral Prostacyclins/K. Albujoq, R. Awdish, L. Yessayan, M.<br />
Mendez, J. Jennings, N. MacDonald, H. Cajigas, S. Hegab, Detroit,<br />
MI, p.A3978<br />
Patients with Pulmonary Arterial Hypertension Less<br />
Represented in Clinical Trials - Who Are They and How Are<br />
They?/G. Kovacs, A. Avian, P. Douschan, V. Foris, A. Olschewski,<br />
H. Olschewski, Graz, Austria, p.A3979<br />
Novel PET Vascular Biomarkers in Pulmonary Arterial<br />
Hypertension/V.J. Kelly, P. Kohli, T. Winkler, E. Kehl, J.<br />
Rodriguez-Lopez, K.A. Hibbert, M. Kone, J.G. Venegas, R.N.<br />
Channick, R.S. Harris, Boston, MA, p.A3980<br />
MONDAY MORNING<br />
ATS 2016 • San Francisco